SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

por Pollet, Jeroen, Chen, Wen-Hsiang, Versteeg, Leroy, Keegan, Brian, Zhan, Bin, Wei, Junfei, Liu, Zhuyun, Lee, Jungsoon, Kundu, Rahki, Adhikari, Rakesh, Poveda, Cristina, Villar, Maria Jose, de Araujo Leao, Ana Carolina, Altieri Rivera, Joanne, Momin, Zoha, Gillespie, Portia M., Kimata, Jason T., Strych, Ulrich, Hotez, Peter J., Bottazzi, Maria Elena
Publicado 2021

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

por Pollet, Jeroen, Strych, Ulrich, Chen, Wen-Hsiang, Versteeg, Leroy, Keegan, Brian, Zhan, Bin, Wei, Junfei, Liu, Zhuyun, Lee, Jungsoon, Kundu, Rahki, Adhikari, Rakesh, Poveda, Cristina, Jose Villar, Maria, Rani Thimmiraju, Syamala, Lopez, Brianna, Gillespie, Portia M., Ronca, Shannon, Kimata, Jason T., Reers, Martin, Paradkar, Vikram, Hotez, Peter J., Elena Bottazzi, Maria
Publicado 2022